Janus Henderson Global Life Sciences Fund A2 HEUR

WKN 935591 | ISIN IE0002122038 |  Fonds
Factsheet
07.04.25
38,51 EUR-0,88 % (-0,34)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 BE0170813936 KBC Equity Fund Medical Technologies Classic +1,04 % +12,39 % -0,10
2 LU2418149048 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse F-acc, USD -1,74 % +13,01 % -0,31
3 LU0358044559 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse Q-acc, USD -2,02 % +13,01 % -0,33
4 LU0085953304 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse P-acc, USD -2,81 % +13,01 % -0,39
5 LU2384387564 CPR Invest - MedTech - A HUF - Acc +0,38 % +14,94 % -0,13
269 IE0002122038 Janus Henderson Global Life Sciences Fund A2 HEUR -12,38 % +14,24 % -1,03
440 IE00BF2ZTL15 Wellington Global Health Care Equity Fund CHF D AccU -19,26 % +15,14 % -1,43
441 LU1864482606 Candriam Equities L Oncology, N-H - Capitalisation -17,62 % +13,51 % -1,48
442 LU2425425506 Candriam Equities L Oncology, V - Capitalisation -15,26 % +12,23 % -1,44
443 LU1864482515 Candriam Equities L Oncology, I - Capitalisation -15,53 % +12,23 % -1,46
444 LU1864482945 Candriam Equities L Oncology, R - Capitalisation -15,61 % +12,23 % -1,47